Aesthetic Considerations for Neuromodulator Use in Transgender Patients.
Journal
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
ISSN: 1524-4725
Titre abrégé: Dermatol Surg
Pays: United States
ID NLM: 9504371
Informations de publication
Date de publication:
01 Sep 2024
01 Sep 2024
Historique:
medline:
29
8
2024
pubmed:
29
8
2024
entrez:
28
8
2024
Statut:
ppublish
Résumé
The aesthetic dimension of transgender experiences involves various aspects linked to the visual representation and expression of one's gender identity. Nonsurgical cosmetic procedures, such as neuromodulators, have consequently become a viable treatment option for patients with gender dysphoria because of the ability to yield significant, although temporary, results with minimal associated risks and downtime. To comprehensively review literature pertaining to the aesthetic considerations for use of neuromodulators in transgender and nonbinary individuals. A literature review of PubMed/MEDLINE for studies was published through January 2024 for nonsurgical facial and body modification using neuromodulators. Searches were conducted with relevant keywords. Peer-reviewed articles and their references published within the past 10 years were given emphasis in the review. Based on the limited publications to date, the authors prepared a comprehensive review on indications for neuromodulator treatment in this population, including brow positioning, lower face contouring, lip eversion, trapezius slimming, and leg contouring. Dermatologists play a crucial role in facilitating the achievement of gender affirmation goals.
Sections du résumé
BACKGROUND
BACKGROUND
The aesthetic dimension of transgender experiences involves various aspects linked to the visual representation and expression of one's gender identity. Nonsurgical cosmetic procedures, such as neuromodulators, have consequently become a viable treatment option for patients with gender dysphoria because of the ability to yield significant, although temporary, results with minimal associated risks and downtime.
OBJECTIVE
OBJECTIVE
To comprehensively review literature pertaining to the aesthetic considerations for use of neuromodulators in transgender and nonbinary individuals.
MATERIALS AND METHODS
METHODS
A literature review of PubMed/MEDLINE for studies was published through January 2024 for nonsurgical facial and body modification using neuromodulators. Searches were conducted with relevant keywords. Peer-reviewed articles and their references published within the past 10 years were given emphasis in the review.
RESULTS
RESULTS
Based on the limited publications to date, the authors prepared a comprehensive review on indications for neuromodulator treatment in this population, including brow positioning, lower face contouring, lip eversion, trapezius slimming, and leg contouring.
CONCLUSION
CONCLUSIONS
Dermatologists play a crucial role in facilitating the achievement of gender affirmation goals.
Identifiants
pubmed: 39196839
doi: 10.1097/DSS.0000000000004325
pii: 00042728-202409001-00017
doi:
Substances chimiques
Neurotransmitter Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
S80-S84Informations de copyright
Copyright © 2024 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.
Références
Herman JL, Flores AR, O’Neil KK. How Many Adults and Youth Identify as Transgender in the United States? Los Angeles, CA: Williams Institute UCLA; 2022.
Cronin BJ, Fadich S, Lee JC. Assessing preferences of facial appearance in transgender and gender nonbinary patients. Aesthet Plast Surg 2024;48:621–32.
Ascha M, Swanson MA, Massie JP, Evans MW, et al. Nonsurgical management of facial masculinization and feminization. Aesthet Surg J 2019;39:NP123–NP137.
Kelly PJ, Frankel AS, D'Avanzo P, Suppes K, et al. Psychosocial differences between transgender individuals with and without history of nonsurgical facial injectables. Aesthet Surg J Open Forum 2021;3:ojaa050.
Teixeira JC, Ostrom JY, Hohman MH, Nuara MJ. Botulinum toxin type-A for lip augmentation: “lip flip.”. J Craniofac Surg 2021;32:E273–E275.
Wu GT, Wong A, Bloom JD. Injectable treatments and nonsurgical aspects of gender affirmation. Facial Plast Surg Clin North Am 2023;31:399–406.
MacGregor JL, Chang YC. Minimally invasive procedures for gender affirmation. Dermatol Clin 2020;38:249–60.
Cheng J, Hsu SH, McGee JS. Botulinum toxin injections for masseter reduction in east asians. Dermatol Surg 2019;45:566–72.
Cheng J, Chung HJ, Friedland M, Hsu SH. Botulinum toxin injections for leg contouring in East asians. Dermatol Surg 2020;46(Suppl 1):S62–S70.
Benítez PA. Onabotulinumtoxin A for correcting trapezius muscle hypertrophy in Asian women. J Cosmet Dermatol 2022;21:2677–9.
Dhingra N, Bonati LM, Wang EB, Chou M, et al. Medical and aesthetic procedural dermatology recommendations for transgender patients undergoing transition. J Am Acad Dermatol 2019;80:1712–21.
Beuttler M, MacGregor J. A genderfluid approach to aesthetic language in dermatology. J Drugs Dermatol. 2022;21:96–99.
Somenek M, Romero NJ. Brow lift and brow position for gender affirmation. Otolaryngol Clin North Am 2022;55:797–808.
Cotofana S, Solish N, Gallagher C, Beleznay K, et al. The anatomy behind eyebrow positioning: a clinical guide based on current anatomic concepts. Plast Reconstr Surg 2022;149:869–79.
Jabbour S, Awaida C, Kechichian E, Rayess Y, et al. Botulinum toxin for eyebrow shaping: a systematic review. Dermatol Surg 2017;43(Suppl 3):S252–S261.
De Boulle K, Furuyama N, Heydenrych I, Keaney T, et al. Considerations for the use of minimally invasive aesthetic procedures for facial remodeling in transgender individuals. Clin Cosmet Investig Dermatol 2021;14:513–25.
Keaney TC, Alster TS. Botulinum toxin in men: review of relevant anatomy and clinical trial data. Dermatol Surg official Publ Am Soc Dermatol Surg [et al.] 2013;39:1434–43.
Biello A, Oney R, Zhu B. Botulinum Toxin Treatment of the Upper Face Continuing Education Activity. Treasure Island, FL: StatPearls Publishing; 2023.
Brandt F, Swanson N, Baumann L, Huber B. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety. Dermatol Surg 2009;35:1893–901.
Kane MAC, Brandt F, Rohrich RJ, Narins RS, et al. Evaluation of variable-dose treatment with a new U.S. botulinum toxin type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, Double-Blind, placebo-controlled study. Plast Reconstr Surg 2009;124:1619–29.
Carruthers A, Carruthers J. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol Surg 2005;31:1297–1303.
Carruthers A, Carruthers J, Said S. Dose-ranging study of botulinum toxin type a in the treatment of glabellar rhytids in females. Dermatol Surg 2005;31:414–422.
Green JB, Keaney TC. Aesthetic treatment with botulinum toxin: approaches specific to men. Dermatol Surg 2017;43(Suppl 2):S153–S156.
Yi KH, Lee HJ, Hur HW, Seo KK, et al. Guidelines for botulinum neurotoxin injection for facial contouring. Plast Reconstr Surg 2022;150:562E–571E.
Li D, Xu L, Yu Z, Yuan J, et al. Necessity of facial contouring in feminization surgery for Chinese transgender females. Ann Transl Med 2021;9:603.
Hong JY, Jeong GJ, Kwon TR, Kim JH, et al. Efficacy and safety of a novel botulinum toxin A for masseter reduction: a randomized, double-blind, placebo-controlled, optimal dose-finding study. Dermatol Surg 2021;47:E5–E9.
Hsu AK, Frankel AS. Modification of chin projection and aesthetics with onabotulinumtoxinA injection. JAMA Facial Plast Surg 2017;19:522–7.
Asokan A, Sudheendran MK. Gender affirming body contouring and physical transformation in transgender individuals. Indian J Plast Surg 2022;55:179–87.
Nolan IT, Shepard E, Swanson M, Morrison SD, et al. Techniques and applications of lower extremity feminization and masculinization. Transgend Health 2023;8:45–55.
Wanitphakdeedecha R, Ungaksornpairote C, Kaewkes A, Sathaworawong A, et al. A pilot study comparing the efficacy of two formulations of botulinum toxin type A for muscular calves contouring. J Cosmet Dermatol 2018;17:984–90.
Bogari M, Tan A, Xin Y, Chai G, et al. Treatment of gastrocnemius muscle hypertrophy with botulinum toxin injection followed by magnetic resonance imaging assessment and 3-dimensional evaluation. Aesthet Surg J 2017;37:1146–56.
Lee HJ, Lee DW, Park YH, Cha MK, et al. Botulinum toxin A for aesthetic contouring of enlarged medial gastrocnemius muscle. Dermatol Surg 2004;30:867–871.
Wang L, Li T, Chi Y, Zhang M, et al. Ultrasonographic analysis of trapezius muscle for efficient botulinum toxin type A injection. Aesthet Plast Surg 2023;47:2029–36.
Supornpun N, Rummaneethorn P, Nararatwanchai T, Saiwichai T, et al. Incobotulinum toxin A with a one-year long-lasting effect for trapezius contouring and superior efficacy for the treatment of trapezius myalgia. J Cutan Aesthet Surg 2022;15:168–74.
Zhou RR, Wu HL, Zhang XD, Ye LL, et al. Efficacy and safety of botulinum toxin type A injection in patients with bilateral trapezius hypertrophy. Aesthet Plast Surg 2018;42:1664–71.
Ginsberg BA. Dermatologic care of the transgender patient. Int J Womens Dermatol 2017;3:65–7.
Ginsberg BA, Calderon M, Seminara NM, Day D. A potential role for the dermatologist in the physical transformation of transgender people: a survey of attitudes and practices within the transgender community. J Am Acad Dermatol 2016;74:303–8.